482
Participants
Start Date
April 5, 2023
Primary Completion Date
October 7, 2026
Study Completion Date
October 7, 2026
mRNA-1195.1
Sterile liquid for injection
mRNA-1195.2
Sterile liquid for injection
mRNA-1189
Sterile liquid for injection
Placebo
0.9% sodium chloride (normal saline) injection
mRNA-1195
Sterile liquid for injection
Velocity Clinical Research, Binghamton
Rochester Clinical Research, Inc, Rochester
DM Clinical Research - Philadelphia, Philadelphia
Velocity Clinical Research, Rockville
Eximia Clinical Research, Raleigh
Velocity Clinical Research, Savannah
Suncoast Research Group, LLC, Miami
Pinnacle Research Group, LLC, Anniston
Alliance for Multispecialty Research, LLC, Knoxville
DM Clinical Research, Southfield
Velocity Clinical Research, Sioux City
DM Clinical Research- River Forest, River Forest
Optimal Research, Peoria
Johnson County Clin-Trials, Inc (JCCT), Lenexa
Velocity Clinical Research, Omaha
Velocity Clinical Research, Lincoln
Velocity Clinical Research, Norfolk
Velocity Clinical Research, Grand Island
Velocity Clinical Research, Hastings
Tekton Research, Inc, Edmond
Tekton Research, Inc - Yukon Location, Yukon
Tekton Research, Moore
Research Your Health, Plano
DM Clinical Research, Houston
DM Clinical Research, Tomball
DM Clinical Research, Sugar Land
Benchmark Research, Austin
Tekton Research Inc., Austin
Tekton Research, Longmont
Noble Clinical Research, Tucson
Las Vegas Clinical Trials, LLC, North Las Vegas
Marvel Clinical Research, Huntington Beach
DM Clinical Research, Brookline
University of Massachusetts Chan Medical School, Worcester
ModernaTX, Inc.
INDUSTRY